A treatment
TARGETED FOR ROS1

FACT

1%-2% of adults with non-small cell lung cancer (NSCLC) are diagnosed with an abnormal ROS1 gene. AUGTYRO is a treatment tailored to treat it, whether you are newly diagnosed or have been previously treated.

See Study Results

You’re not alone. Sign up for this complimentary program to learn about support and advocacy groups and get tools to help you during your journey.

Sign up now